Last month Senators Chuck Grassley (R-Iowa), Dianne Feinstein (D-Calif.), Amy Klobuchar (D-Minn.), John Kennedy (R-La.) and Sheldon Whitehouse (D-R.I.) separately wrote to Google, Microsoft, Yahoo and Pinterest accusing them of facilitating
consider removing from its platform content that advertises the use of or enables the sale of illicit narcotics, including the sale of prescription drugs without a valid prescription.We further request that[it] consider action to ensure that future, similar content is banned.
The letterspecifies that the platforms concerned should censor search results for illicit drugs, and ensure that when users search for prescription medicines theybe "automatically directed" to approved U.S.-based suppliers. Attachments to the letters includeprintouts of organic search listings, with a few results on each page circled, apparently containing information about suppliers who will sell drugs without prescription. (The same printouts revealsome stern anti-drug warnings in the top few results, both organic and paid.)
The letters were announced in a mailing to members of theAlliance for Safe Online Pharmacies (ASOP), apharma industry lobby group, on the same day that the letters were sent.(Beyond that, we don't know whether there was any coordination between the Senators andASOP in drafting the letter; and because Congress is exempt from FOIA requests, itwould be difficult for us to find out.)
ASOP is alsoone of the principal contributors to United States Trade Representative (USTR) reports such as the Special 301 Report and the Notorious Markets List, and it makes similar censorship demands inits submissions to those reports. For example in its submission [PDF] to the 2017 Notorious Markets report, ASOP recommends that domain name registrars should "voluntarily lock and suspend illegitimate websites" rather than requiring a court order.
By "illegitimate", ASOP doesn'tmean that the website is selling fake drugs; its complaint extends to branded drugs thatare merely "transported without the requisite quality controls" (ie. sent through the mail). Neitheris it targeting onlyrecreational drugs; ASOP's submission acknowledges that most overseas drug sales are for "chronic illness and/or maintenance drugs for diseases such as HIV/AIDS, hypertension, [and] hypercholesterolemia." Rather, an "illegitimate" online pharmacyin ASOP lingo is one thatdoesn't comply with U.S. law that prohibits online medicine sales from overseaseven though, because they are overseas, they are not actually subject to U.S. law inthe first place.
There might well be a case to be made for tighter regulation of sales of prescription and non-prescription drugs online. But to progress from that proposition to the proposal that information aboutsuch drugs should becensored from search engines and online marketplaces, and without a court order at that, is quite a leap. It's concerning that ASOP's recommendations are often incorporated holus bolus into the USTR's reports without independent verification, andthat the responsibility for fact-checking of its claims is placed on rebuttal submissions from third-parties.
We are even more concerned about the approach taken by the Senators who wrote the letter to major platforms. For U.S. Senators, with the imprimatur of official authority that their offices represent,to prevail on platforms to privately censor content, is a blatant form of Shadow Regulation, intended to intimidate them into compliance.
If the Senatorsare serious in theirdesirefor theseInternet platforms to censor organic search results, theycould table a billaimed at achieving that object,and have it debated in both houses of Congress. Instead, knowing that such a law would likely be unconstitutional, they are seeking to achieve the same resultwithout a transparent and accountable lawmaking process. The Senators should know better, and we encourage platforms receiving such letters to resisttheseextra-legal demands.